Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1995-12-18
|
pubmed:abstractText |
A series of 3-(3-guanidinopropyl)-azetidin-2-one derivatives was prepared and evaluated as inhibitors of cleavage of synthetic substrates in vitro by the serine proteases thrombin, trypsin and plasmin. The N-unsubstituted, 4-phenethyl derivative 9a demonstrated weak inhibition of these enzymes but acetylation of the beta-lactam N atom afforded 9b, an effective, time-dependent inhibitor of thrombin and a potent inhibitor of plasmin. Variation of the 4-position of the beta-lactam ring was examined in conjunction with different N-substituents to provide a series of potent, time-dependent inhibitors of thrombin. A C-4 substituent was essential for good inhibitory properties and, in general, polar C-4 substituents enhanced the selectivity of inhibition for thrombin compared to plasmin. A trans relationship between the C-4 and C-3 substituents was found to be superior to a cis disposition whilst homologation of the guanidinopropyl side chain to that of a guanidinobutyl moiety reduced activity. Several compounds were effective inhibitors of thrombin-induced clot formation in human plasma in vitro but activity in this assay did not correlate well with inhibition of thrombin-induced cleavage of a synthetic substrate, presumably a consequence of inherent chemical instability and degradation in plasma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antithrombins,
http://linkedlifedata.com/resource/pubmed/chemical/Azetidines,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolysin,
http://linkedlifedata.com/resource/pubmed/chemical/Guanidines,
http://linkedlifedata.com/resource/pubmed/chemical/Indicators and Reagents,
http://linkedlifedata.com/resource/pubmed/chemical/Serine Proteinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Trypsin Inhibitors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0968-0896
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1123-43
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:7582985-Antithrombins,
pubmed-meshheading:7582985-Azetidines,
pubmed-meshheading:7582985-Drug Design,
pubmed-meshheading:7582985-Fibrinolysin,
pubmed-meshheading:7582985-Guanidines,
pubmed-meshheading:7582985-Humans,
pubmed-meshheading:7582985-Indicators and Reagents,
pubmed-meshheading:7582985-Kinetics,
pubmed-meshheading:7582985-Magnetic Resonance Spectroscopy,
pubmed-meshheading:7582985-Molecular Structure,
pubmed-meshheading:7582985-Serine Proteinase Inhibitors,
pubmed-meshheading:7582985-Spectrometry, Mass, Fast Atom Bombardment,
pubmed-meshheading:7582985-Spectrophotometry, Infrared,
pubmed-meshheading:7582985-Structure-Activity Relationship,
pubmed-meshheading:7582985-Thrombin,
pubmed-meshheading:7582985-Trypsin Inhibitors
|
pubmed:year |
1995
|
pubmed:articleTitle |
Azetidin-2-one derivatives as inhibitors of thrombin.
|
pubmed:affiliation |
Division of Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492-7660, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|